N2Growth Blog

OCTOBER 23, 2023

Additionally, the industry’s highly regulated nature means that executives must have a keen eye for compliance and a strong ability to navigate the ever-changing market dynamics. One of the primary obstacles is the need for more highly skilled and qualified talent.

Execution 437

Execution Strategy Compliance Industry 437

Harvard Business Review

MAY 7, 2018

She was on the legal compliance team at a fast-growing biotechnology company. Her role was to work with marketing to ensure that promotional campaigns and materials were in line with government guidelines. When I spoke with Karen’s marketing colleagues, they told me that they found her presence in meetings frustrating.

Restructuring 9

Restructuring How To Compliance Biotechnology 9

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

FEBRUARY 16, 2016

However, outside North America they tend to be more optimistic about emerging economies: 36% of directors in Asia, 24% of directors in Australia and New Zealand, and 23% of directors in Africa predict faster growth in emerging economies than in developed countries in the next three years.

Politics 8

Politics Telecommunications Policies Biotechnology 8